AbbVie's rheumatoid arthritis drug succeeds in late-stage trial

(Reuters) - U.S. drugmaker AbbVie Inc said on Wednesday its drug to treat moderate-to-severe rheumatoid arthritis met the main goal in a late-stage study.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news